XML 55 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue Recognition (Tables)
12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table represents Evolent’s revenue disaggregated by segment and end-market for the years ended December 31, 2022, 2021 and 2020 (in thousands):
For the Year Ended December 31,
202220212020202220212020
Evolent Health ServicesClinical Solutions
Medicaid$238,504 $215,236 $236,634 $320,858 $205,833 $274,028 
Medicare27,092 26,358 68,505 431,321 380,973 258,905 
Commercial and other141,906 68,219 77,221 192,332 11,338 9,346 
Total$407,502 $309,813 $382,360 $944,511 $598,144 $542,279 
Schedule of Contract with Customer, Asset and Liability
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers as of December 31, 2022 and 2021 (in thousands):
December 31,
20222021
Short-term receivables (1)
$246,209 $129,012 
Long-term receivables (1)
— 4,877 
Short-term deferred revenue5,758 11,944 
Long-term deferred revenue2,533 4,437 
————————
(1)Excludes pharmacy claims receivable and premiums receivable.

Changes in deferred revenue for the year ended December 31, 2022, are as follows (in thousands):
Deferred revenue
Balance as of beginning-of-period$16,381 
Reclassification to revenue, as a result of performance obligations satisfied(11,901)
Cash received in advance of satisfaction of performance obligations3,811 
Balance as of end of period$8,291